$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx

$amrx Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000172312819000079 Filed on May 09, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$446.1M	$0.00
YoY Change		-100.0%
Cost Of Revenue	$309.7M	$130.6M
YoY Change	137.18%	-18.12%
Gross Profit	$83.08M	$144.6M
YoY Change	-42.54%	24.63%
Gross Profit Margin	18.62%
Selling, General & Admin	$84.44M	$25.12M
YoY Change	236.12%	-46.66%
% of Gross Profit	101.63%	17.37%
Research & Development	$53.86M	$44.21M
YoY Change	21.83%	96.48%
% of Gross Profit	64.83%	30.57%
Depreciation & Amortization	$48.90M	$14.80M
YoY Change	230.41%	-42.64%
% of Gross Profit	58.86%	10.24%
Operating Expenses	$138.3M	$0.00
YoY Change		-100.0%
Operating Profit	-$94.36M	$63.55M
YoY Change	-248.47%	36.63%
Interest Expense	-$43.28M	-$21.05M
YoY Change	105.6%	59.48%
% of Operating Profit		-33.12%
Other Income/Expense, Net	-$38.82M	-$11.54M
YoY Change	236.45%	787.54%
Pretax Income	-$133.2M	$52.02M
YoY Change	-356.04%	-177.06%
Income Tax	-$8.000M	$400.0K
% Of Pretax Income		0.77%
Net Earnings	-$47.88M	$0.00
YoY Change		-100.0%
Net Earnings / Revenue	-10.73%
Basic Earnings Per Share	-$0.37	$0.00
Diluted Earnings Per Share	-$0.37	$0.00
COMMON SHARES
Basic Shares Outstanding	127.7M	1.000K shares
Diluted Shares Outstanding	127.7M

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.90M	$48.20M
YoY Change	32.57%	-69.36%
Cash & Equivalents	$63.95M	$48.22M
Short-Term Investments
Other Short-Term Assets	$114.4M	$41.70M
YoY Change	174.34%	54.44%
Inventory	$448.3M	$327.9M
Prepaid Expenses
Receivables	$640.2M	$346.7M
Other Receivables	$1.200M	$11.00M
Total Short-Term Assets	$1.268B	$0.00
YoY Change		-100.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$514.4M	$489.9M
YoY Change	5.0%	103.96%
Goodwill	$421.6M
YoY Change
Intangibles	$1.591B
YoY Change
Long-Term Investments
YoY Change
Other Assets	$62.42M	$18.90M
YoY Change	230.28%	-80.43%
Total Long-Term Assets	$3.117B	$0.00
YoY Change		-100.0%
TOTAL ASSETS
Total Short-Term Assets	$1.268B	$0.00
Total Long-Term Assets	$3.117B	$0.00
Total Assets	$4.385B	$0.00
YoY Change		-100.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$558.8M	$84.20M
YoY Change	563.66%	14.71%
Accrued Expenses	$15.40M	$129.0M
YoY Change	-88.06%	-44.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$75.00M
YoY Change	-100.0%
Long-Term Debt Due	$22.50M	$14.40M
YoY Change	56.25%	-19.1%
Total Short-Term Liabilities	$599.5M	$0.00
YoY Change		-100.0%
LONG-TERM LIABILITIES
Long-Term Debt	$2.625B	$1.392B
YoY Change	88.56%	81.96%
Other Long-Term Liabilities	$37.72M	$20.30M
YoY Change	85.83%	-58.23%
Total Long-Term Liabilities	$2.985B	$1.413B
YoY Change	111.35%	73.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$599.5M	$0.00
Total Long-Term Liabilities	$2.985B	$1.413B
Total Liabilities	$3.585B	$0.00
YoY Change		-100.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.84M
YoY Change
Common Stock		$10.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$472.2M	$0.00
YoY Change
Total Liabilities & Shareholders Equity	$4.385B	$0.00
YoY Change		-100.0%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	-$47.88M	$0.00
YoY Change		-100.0%
Depreciation, Depletion And Amortization	$48.90M	$14.80M
YoY Change	230.41%	-42.64%
Cash From Operating Activities	-$108.4M	$27.03M
YoY Change	-501.09%	-32.09%
INVESTING ACTIVITIES
Capital Expenditures	$17.99M	$19.50M
YoY Change	-7.75%	-324.13%
Acquisitions	$0.00
YoY Change
Other Investing Activities	-$3.500M
YoY Change
Cash From Investing Activities	-$21.47M	-$19.50M
YoY Change	10.09%	137.79%
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00	$30.00M
YoY Change	-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-21.86M	-$33.25M
YoY Change	-34.24%	-40.74%
NET CHANGE
Cash From Operating Activities	-108.4M	$27.03M
Cash From Investing Activities	-21.47M	-$19.50M
Cash From Financing Activities	-21.86M	-$33.25M
Net Change In Cash	-152.0M	-$25.31M
YoY Change	500.81%	3.29%
FREE CASH FLOW
Cash From Operating Activities	-$108.4M	$27.03M
Capital Expenditures	$17.99M	$19.50M
Free Cash Flow	-$126.4M	$7.530M
YoY Change	-1778.59%	-84.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	amrx	Additional Liabilities Under Tax Receivable Agreement Noncurrent AdditionalLiabilitiesUnderTaxReceivableAgreementNoncurrent	600000	USD
CY2018Q4	amrx	Allowance For Accounts Receivable Current AllowanceForAccountsReceivableCurrent	868093000	USD
CY2019Q1	amrx	Allowance For Accounts Receivable Current AllowanceForAccountsReceivableCurrent	798084000	USD
CY2018Q1	amrx	Amortization Transition Agreement Payment AmortizationTransitionAgreementPayment	0	USD
CY2019Q1	amrx	Amortization Transition Agreement Payment AmortizationTransitionAgreementPayment	36393000	USD
CY2018Q1	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-8595000	USD
CY2018Q1	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	7135000	USD
CY2019Q1	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	6032000	USD
CY2018Q4	amrx	Cash Discount Allowances Current CashDiscountAllowancesCurrent	36157000	USD
CY2019Q1	amrx	Cash Discount Allowances Current CashDiscountAllowancesCurrent	51889000	USD
CY2018	amrx	Concentration Risk Number Of Largest Customers ConcentrationRiskNumberOfLargestCustomers	3	customer
CY2019Q1	amrx	Concentration Risk Number Of Largest Customers ConcentrationRiskNumberOfLargestCustomers	3	customer
CY2018Q4	amrx	Contract Charge Backs And Sales Volume Allowances Current ContractChargeBacksAndSalesVolumeAllowancesCurrent	829596000	USD
CY2019Q1	amrx	Contract Charge Backs And Sales Volume Allowances Current ContractChargeBacksAndSalesVolumeAllowancesCurrent	743522000	USD
CY2018Q1	amrx	Cost Of Goods And Services Sold Impairment Charges CostOfGoodsAndServicesSoldImpairmentCharges	0	USD
CY2019Q1	amrx	Cost Of Goods And Services Sold Impairment Charges CostOfGoodsAndServicesSoldImpairmentCharges	53297000	USD
CY2018Q1	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	14751000	USD
CY2019Q1	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	48868000	USD
CY2019Q1	amrx	Finance Lease Cost FinanceLeaseCost	1776000	USD
CY2019Q1	amrx	Finite Lived Intangible Assets Amortization Expense After Year Six FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix	380278000	USD
CY2019Q1	amrx	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	120244000	USD
CY2018Q4	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	192884000	USD
CY2018Q4	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	193000000	USD
CY2019Q1	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	193000000	USD
CY2019Q1	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	193499000	USD
CY2018Q1	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	51535000	USD
CY2019Q1	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	0	USD
CY2018Q1	amrx	Tax Distribution To Noncontrolling Interest Financing Activities TaxDistributionToNoncontrollingInterestFinancingActivities	0	USD
CY2019Q1	amrx	Tax Distribution To Noncontrolling Interest Financing Activities TaxDistributionToNoncontrollingInterestFinancingActivities	13494000	USD
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001723128
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	Amneal Pharmaceuticals, Inc.
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	AMRX
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	514440000	USD
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1124000	USD
CY2019Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	558750000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1349588000	USD
CY2019Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1438296000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	481495000	USD
CY2019Q1	amrx	Noncontrolling Interest Decreasefrom Distributionsto Noncontrolling Interest Holders Tax Distribution NoncontrollingInterestDecreasefromDistributionstoNoncontrollingInterestHoldersTaxDistribution	82000	USD
CY2019Q1	amrx	Number Of Product Families NumberOfProductFamilies	200	product
CY2018Q1	amrx	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	2000000	USD
CY2019Q1	amrx	Operating And Finance Lease Expense OperatingAndFinanceLeaseExpense	7000000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	640212000	USD
CY2019Q1	amrx	Operating Short Term And Variable Lease Cost OperatingShortTermAndVariableLeaseCost	5940000	USD
CY2018Q1	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	-9957000	USD
CY2019Q1	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	0	USD
CY2018Q1	amrx	Paymentsfor Repurchaseof Noncontrolling Interest PaymentsforRepurchaseofNoncontrollingInterest	0	USD
CY2019Q1	amrx	Paymentsfor Repurchaseof Noncontrolling Interest PaymentsforRepurchaseofNoncontrollingInterest	2011000	USD
CY2018Q2	amrx	Shares Repurchased Percentage SharesRepurchasedPercentage	0.15
CY2019Q1	amrx	Stock Repurchased And Reissued During Period Value StockRepurchasedAndReissuedDuringPeriodValue	223000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7755000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4099000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	530438000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	537159000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4347000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2340000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2673000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1170000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1601000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1760000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30963000	USD
CY2018Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	22787000	USD
CY2018Q4	us-gaap	Assets Assets	4352736000	USD
CY2019Q1	us-gaap	Assets Assets	4384586000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1286644000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	1267968000	USD
CY2018Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-74077000	USD
CY2018Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	417544000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	134566000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5474000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44199000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	130594000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5474000	USD
CY2019Q1	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	3478000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	0	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	107196000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	95217000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	39349000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	5474000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48224000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213394000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63946000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77922000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52617000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218779000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	66743000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25305000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-152036000	USD
CY2018Q1	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	309743000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	3270000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	13561000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	373159000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	382941000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-512000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9884000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1178000	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2018Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2019Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	8818000	USD
CY2018Q1	us-gaap	Distribution Made To Limited Partner Cash Distributions Declared DistributionMadeToLimitedPartnerCashDistributionsDeclared	38562000	USD
CY2018Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8562000	USD
CY2019Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2018Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	830000	USD
CY2019Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1156000	USD
CY2018Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	17695000	USD
CY2019Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2928000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-296000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.063
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	128244000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	652000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.071
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	152413000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	153738000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P24Y
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	91597000	USD
CY2019Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	750000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	63273000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	64000000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	132741000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	106740000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	5474000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	5474000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	5474000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	5474000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	4105000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	69468000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	619000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	64000000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	110633000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	90200000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	136898000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1294636000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1272648000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1203039000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1162015000	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	8565000	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5464000	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	8327000	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-6490000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	26444000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	426226000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	421640000	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	401488000	USD
CY2019Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2018	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1706000	USD
CY2019Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	111000	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4697000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	144595000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	83080000	USD
CY2018Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2019Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	76084000	USD
CY2019Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	76000000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	52016000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-133180000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	364000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	400000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8428000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8000000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1510000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9713000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15325000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	695000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4981000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	165012000	USD
CY2018Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-5215000	USD
CY2019Q1	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	314000	USD
CY2018Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-10542000	USD
CY2019Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	656000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	47589000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14180000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1491000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-22657000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	451930000	USD
CY2019Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	429143000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1746566000	USD
CY2019Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1701791000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1654969000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1591158000	USD
CY2018Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-21051000	USD
CY2019Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-43281000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	18843000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	40032000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	221413000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	207975000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	457219000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	448294000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	181654000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	182590000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	54152000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	57729000	USD
CY2018Q1	us-gaap	Inventory Write Down InventoryWriteDown	2845000	USD
CY2019Q1	us-gaap	Inventory Write Down InventoryWriteDown	15650000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	7716000	USD
CY2018Q1	us-gaap	Legal Fees LegalFees	4576000	USD
CY2019Q1	us-gaap	Legal Fees LegalFees	4166000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2902523000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	100336000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	26939000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	10050000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	10169000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	18354000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	19824000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	15000000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18301000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4352736000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4384586000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	553850000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	599530000	USD
CY2019Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2985275000	USD
CY2017Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-375582000	USD
CY2018Q1	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-368819000	USD
CY2018Q4	us-gaap	Litigation Reserve LitigationReserve	15000000	USD
CY2019Q1	us-gaap	Litigation Reserve LitigationReserve	15000000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	21449000	USD
CY2019Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	21445000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2630598000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2625152000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	391613000	USD
CY2019Q1	us-gaap	Minority Interest MinorityInterest	327576000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-33246000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21864000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19499000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21466000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27029000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-108410000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	117000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-76871000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47881000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	USD
CY2019Q1	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	35837000	USD
CY2018Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	360000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-11538000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-38820000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	63554000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-94360000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	82035000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	80803000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	86000000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4897000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-9957000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	4927000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85000000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.059
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	97561000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	25885000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	10043000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	10329000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11105000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	12071000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	28128000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	67592000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	62422000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	5236000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-9957000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8609000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax	-3373000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-3373000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3682000	USD
CY2018Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	7135000	USD
CY2019Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	12193000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38780000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	37723000	USD
CY2018Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3431000	USD
CY2019Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1109000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	948000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1107000	USD
CY2018Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	30000000	USD
CY2019Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2018Q4	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	3000000	USD
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5000000	USD
CY2019Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	50000000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19499000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	17988000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	128321000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	111563000	USD
CY2018Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	360000	USD
CY2019Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	51652000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-124752000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1010000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	544146000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	514414000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3543000	USD
CY2019Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	6750000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44209000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	53858000	USD
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	4393000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5385000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2797000	USD
CY2018Q1	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	6161000	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	6000000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20920000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63844000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	275189000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	446120000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	360000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25121000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	84436000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4347000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1010000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	504750000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	472205000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	896363000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	799781000	USD
CY2019Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-502000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	127687000	shares
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements, which are prepared in accordance with generally accepted accounting principles in the United States, requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, bill backs, allowances for accounts receivable, accrued liabilities, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights, allowances for deferred tax assets and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name	View Source	Status
0001723128-19-000079-index-headers.html	Edgar Link	pending
0001723128-19-000079-index.html	Edgar Link	pending
0001723128-19-000079.txt	Edgar Link	pending
0001723128-19-000079-xbrl.zip	Edgar Link	pending
amrx-03x31x201910qdoc.htm	Edgar Link	pending
amrx-03x31x2019xex311stewa.htm	Edgar Link	pending
amrx-03x31x2019xex312brann.htm	Edgar Link	pending
amrx-03x31x2019xex321stewa.htm	Edgar Link	pending
amrx-03x31x2019xex322brann.htm	Edgar Link	pending
amrx-20190331.xml	Edgar Link	completed
amrx-20190331.xsd	Edgar Link	pending
amrx-20190331_cal.xml	Edgar Link	unprocessable
amrx-20190331_def.xml	Edgar Link	unprocessable
amrx-20190331_lab.xml	Edgar Link	unprocessable
amrx-20190331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx

2019 Q1 Form 10-Q Financial Statement

#000172312819000079 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRX Amneal Pharmaceuticals, Inc. Stock $amrx

2019 Q1 Form 10-Q Financial Statement

#000172312819000079 Filed on May 09, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx